Huttig Bldg Products (HBP) 6.24 $HBP Helix BioPharma

New Post Public Reply Private Reply Replies (0) Message Board

Jul 10, 2016 at 11:02 PM

Huttig Bldg Products (HBP) 6.24 $HBP

Helix BioPharma Corp. Announces L-DOS47 Immuno-Oncology Scientific Presentation at the Medical University of Warsaw
Marketwire Canada - Mon Jun 27, 6:30AM CDT
AURORA, ON--(Marketwired - Jun 27, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a immune-oncology company developing drug candidates for the prevention and treatment of cancer, today announced that Helix's Chief Scientific Officer, Dr. Heman Chao will be making a presentation on Tuesday, June 28, 2016 at the Strategies Towards Excellence in Immuno-Oncology symposium at the Medical University of Warsaw in Poland.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Helix BioPharma Corp. Appoints Evolution Life Science Partners as Advisors
Marketwired - Thu Jun 02, 7:00AM CDT
AURORA, ON--(Marketwired - Jun 2, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Evolution Life Science Partners to act as advisors to the Company. Activities the Company may pursue could include, but are not limited to, partnering or other collaboration agreements. The Company does not intend to disclose developments with respect to this process except as required under applicable securities regulations.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Huttig Adopts Rights Plan to Protect Net Operating Loss Carryforwards
Marketwire Canada - Thu May 19, 3:30PM CDT
ST. LOUIS, MO --(Marketwired - May 19, 2016) - Huttig Building Products, Inc. ("Huttig"

(NASDAQ: HBP) today announced that its Board of Directors has adopted a rights plan as a measure to protect the Company's existing net operating loss carryforwards ("NOLs"

and preserve the Company's ability to use its NOLs to offset future taxable income, without limitation. As of March 31, 2016, the Company had Federal NOL carryforwards of approximately $55 million. The Company intends to seek stockholder approval of the rights plan at its 2017 Annual Meeting of Stockholders.
HBP: 6.24 (+0.30)

First Patient Dosed in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Wed May 11, 6:30AM CDT
AURORA, ON--(Marketwired - May 11, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the first patient was dosed in the Phase II component of study LDOS002.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Helix BioPharma Corp. Subsidiary, Helix Polska Sp zo.o., Qualifies for CAD4.1 Million Grant From the Polish National Center for Research and Development
Marketwire Canada - Mon May 09, 6:30AM CDT
AURORA, ON--(Marketwired - May 9, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that its wholly owned subsidiary, Helix Polska Sp. z o.o. qualifies for a grant of approximately PLN12.5mil from the Polish National Centre for Research and Development to develop V-DOS47 in breast cancer. The acceptance of the grant is subject to review and approval of the final terms and conditions by Helix's management and Board of Directors and may be subject to conditions imposed by the granting authority and corporate or other approvals.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Huttig posts 1Q profit
Automated Insights - Mon May 02, 3:57PM CDT
ST LOUIS (AP) _ Huttig Building Products Inc. (HBP) on Monday reported profit of $1.4 million in its first quarter.
HBP: 6.24 (+0.30)

Huttig Building Products, Inc. Announces First Quarter 2016 Results
Marketwired - Mon May 02, 3:30PM CDT
First Quarter 2016 Highlights:
HBP: 6.24 (+0.30)

Helix BioPharma Corp. Closes CAD4.7 Million Private Placement Financing
Marketwired - Fri Apr 29, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for aggregate gross proceeds of approximately CAD4.7 million.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

First Patient Enrolled in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 28, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the first patient has been enrolled in the Phase II component of study LDOS002.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Trial Steering Committee Recommends Initiation of Phase II L-DOS47 Study in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 21, 4:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a clinical stage biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the recommendation by the Trial Steering Committee to initiate the Phase II component of the LDOS002 study.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Helix BioPharma Corp. Announces Important Additions to Its Leadership Team
Marketwire Canada - Wed Apr 20, 6:30PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"

, a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Dr. Patrick Frankham to Chief Operating Officer and the promotion of Mr. Steve Demas to the position of Chief Medical Officer. Dr. Frankham and Mr. Demas will both report directly to Dr. Sven Rohmann, Helix's newly appointed Chief Executive Officer.
HBP: 6.24 (+0.30), HBP.TO: 2.00 (unch)

Huttig Building Products Schedules First Quarter 2016 Earnings Call
Marketwired - Mon Apr 18, 3:30PM CDT
Huttig Building Products (NASDAQ: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to report its first quarter 2016 financial results before the market opens on Tuesday, May 3, 2016. A conference call with management to review the results and current market conditions is scheduled on the same day at 10:00 am Central Time. The call will be hosted by Jon Vrabely, President and CEO and Oscar Martinez, Vice President and CFO.
HBP: 6.24 (+0.30)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

University of Phoenix Unveils Credit for Prior Learning Advantages

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Cowfest 2026 Delighted by Frederick's Flying Cows

Moo-ving Towards a New Record Alright, listen up. This fall, there's a bovine spectacle coming to Maryland that's more than just a trip down to the fairgrounds—it's Cowfest 2026, baby! Now, if you're scratching your head thinking this is just another seasonal shindig, you're underestimating what's mooing across Frederick County. The Flying Cows are ready to take the...

Empire Steak House Expands to Delray Beach

Steakhouse Kings Bring New York Flavors to Florida When you're talking about steak, the Empire Steak House name carries some serious heft. This isn't just another restaurant chain cashing in on prime cuts; it's a family legacy over 21 years in the making. The Sinanaj Brothers, who honed their skills at Peter Luger in New York, are moving their empire south, landing a...

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Parents Nationwide Rally for Youth Online Safety Imperative

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Aberdeen's Reverse Split: What Investors Need to Know

Tackling Aberdeen's New Playbook Aberdeen Multi-Market Income Fund (NYSE: MMT) is pulling the trigger on a 1-for-4 reverse stock split come November 9, 2026. This isn't your average headline-grabbing move but one that could shake up how MMT trades. It’s a classic case of tidying up shop, aiming to bolster the share price and streamline share trading. No Change in Fund...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...